Truist Financial Maintains Wave Life Sciences(WVE.US) With Buy Rating

儲億銀行維持Wave Life Sciences(WVE.US)買入評級

moomoo資訊 · 10/17 11:31 · 評級/大行評級

Truist Financial analyst Joon Lee maintains $Wave Life Sciences (WVE.US)$ with a buy rating.

According to TipRanks data, the analyst has a success rate of 56.8% and a total average return of 30.2% over the past year.

AnalystRecentRatingAutoNews_211469_20241017_99b2cd7ef9fabcf3abdb272387ac0ba34ced4bcb_1729305071826340_mm_en

Furthermore, according to the comprehensive report, the opinions of $Wave Life Sciences (WVE.US)$'s main analysts recently are as follows:

The firm has updated its model following the recent RestorAATion-2 AATD data and Takeda's decision not to proceed. Essential revisions encompass increased probability of success estimations for the alpha-1 antitrypsin deficiency program and the transformation of the Huntington's disease initiative from a joint venture to a solely owned project.
The firm's adjusted outlook on Wave Life Sciences is due to data that mitigates risk concerning key programs, and an increased valuation of the pipeline and technology following encouraging updates across various therapeutic modalities.

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

儲億銀行分析師Joon Lee維持$Wave Life Sciences (WVE.US)$買入評級。

根據TipRanks數據顯示，該分析師近一年總勝率為56.8%，總平均回報率為30.2%。

AnalystRecentRatingAutoNews_211469_20241017_99b2cd7ef9fabcf3abdb272387ac0ba34ced4bcb_1729305071826340_mm_tc

此外，綜合報道，$Wave Life Sciences (WVE.US)$近期主要分析師觀點如下：

根據最近的Restoraation-2 AATD數據以及武田決定不繼續操作，該公司已經更新了其模型。基本修訂包括提高α-1抗胰蛋白酶缺乏計劃的成功概率，以及將亨廷頓氏病計劃從合資企業轉變爲獨資項目。
該公司調整後的Wave Life Sciences展望是由於數據減輕了關鍵項目的風險，以及在各種治療模式出現令人鼓舞的更新之後，該產品線和技術的估值有所提高。

提示:

TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。

TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。

分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。

總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。更多信息

Truist Financial Maintains Wave Life Sciences(WVE.US) With Buy Rating

Truist Financial Maintains Wave Life Sciences(WVE.US) With Buy Rating

風險及免責聲明

聲明